Material Insights · Understanding the Material World

Combination antiretroviral therapy: Evolution

Timeline

The milestones from first idea to today

YearMilestone
1983The Institut Pasteur team publishes the first description of HIV [3]
1987AZT becomes the first FDA-approved drug for AIDS [1]
1995Saquinavir becomes the first approved protease inhibitor; the ACTG 175 trial shows two drugs beat one [1]
1996Triple-drug therapy is found to suppress HIV durably [1]
2007Raltegravir, the first integrase inhibitor, is approved [1]
2013Dolutegravir, a second-generation integrase inhibitor, is approved [1]
202532.1 million people are on treatment worldwide [2]

as of 2026-11-11

Performance then and now

How much better it has become on the measures that matter

MetricUnitThenYear (then)NowYear (now)
price of a year's antiretroviral treatment per person in poorer countriesUSD per person per year10,00020001002016

as of 2026-11-11. 2000: a basic regimen cost over $10,000 per person per year; 2016: the lowest generic price of a WHO-recommended first-line regimen was $100 [5]; the two prices are for different regimens and the source does not say whether dollars are nominal or real.

Lineage

The technologies it came from and the ones that came from it

Came before it Works with
  • Syr Hypodermic syringe Long-acting injectable treatment, studied in trials presented in 2024, is an alternative to daily pills [1].
  • PCR Polymerase chain reaction PCR-based tests detect HIV and measure the amount of virus in the blood, which shows whether treatment is working.

as of 2026-11-11

Sources

  1. Antiretroviral Drug Discovery and Development National Institute of Allergy and Infectious Diseases (NIH)
  2. Fact sheet 2026 UNAIDS, 2026
  3. Nobel Prize in Medicine 2008 awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier Institut Pasteur, 2008